These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. A study on pulmonary complications of systemic sclerosis in eastern India. Ghosh A, Banerjee A, Biswas AK. Indian J Chest Dis Allied Sci; 2014 Jul 25; 56(4):231-5. PubMed ID: 25962196 [Abstract] [Full Text] [Related]
10. [Diagnostic value of the static compliance and carbon monoxide diffusion capacity in the verification of a pulmonary fibrosis associated with silicoses]. Mährlein W. Z Erkr Atmungsorgane Folia Bronchol; 1971 Jul 25; 135(2):217-24. PubMed ID: 5211696 [No Abstract] [Full Text] [Related]
14. Improved pulmonary function in systemic sclerosis after treatment with cyclophosphamide. Akesson A, Scheja A, Lundin A, Wollheim FA. Arthritis Rheum; 1994 May 25; 37(5):729-35. PubMed ID: 8185701 [Abstract] [Full Text] [Related]
15. Correlation of the degree of dyspnea with health-related quality of life, functional abilities, and diffusing capacity for carbon monoxide in patients with systemic sclerosis and active alveolitis: results from the Scleroderma Lung Study. Khanna D, Clements PJ, Furst DE, Chon Y, Elashoff R, Roth MD, Sterz MG, Chung J, FitzGerald JD, Seibold JR, Varga J, Theodore A, Wigley FM, Silver RM, Steen VD, Mayes MD, Connolly MK, Fessler BJ, Rothfield NF, Mubarak K, Molitor J, Tashkin DP, Scleroderma Lung Study Group. Arthritis Rheum; 2005 Feb 25; 52(2):592-600. PubMed ID: 15692967 [Abstract] [Full Text] [Related]
16. Serial changes in scleroderma and idiopathic interstitial lung disease. Colp CR, Riker J, Williams MH. Arch Intern Med; 1973 Oct 25; 132(4):506-15. PubMed ID: 4742404 [No Abstract] [Full Text] [Related]
17. Assessments of pulmonary involvement in patients with systemic sclerosis. Gohari Moghadam K, Gharibdoost F, Parastandechehr G, Salehian P. Arch Iran Med; 2011 Jan 25; 14(1):22-6. PubMed ID: 21194257 [Abstract] [Full Text] [Related]